Cromolyn compositions for treatment of pulmonary fibrosis
Abstract:
The disclosure provides a method of treating pulmonary fibrosis, including idiopathic pulmonary fibrosis, in a comprising administering to the subject a pharmaceutical composition comprising from about 1% by weight to about 99% by weight of cromolyn sodium with an inhalation device.
Public/Granted literature
Information query
Patent Agency Ranking
0/0